Can hepatitis B (Hepatitis B vaccine), DTaP (Diphtheria, Tetanus, and Pertussis vaccine), MMR (Measles, Mumps, and Rubella vaccine), and varicella (Varicella vaccine) vaccines be administered together in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, Hepatitis B, DTaP, MMR, and Varicella Vaccines Can and Should Be Administered Together

All vaccines appropriate to the age and previous vaccination status of the child should be administered simultaneously, including DTaP, hepatitis B vaccine, MMR vaccine, and varicella vaccine. 1

Evidence Supporting Simultaneous Administration

The Advisory Committee on Immunization Practices (ACIP) explicitly recommends that DTaP may be administered simultaneously with hepatitis B vaccine, MMR vaccine, and varicella vaccine based on extensive clinical experience and data. 1

Key Supporting Data:

  • Clinical trial evidence: A large randomized trial involving 1,915 children aged 12-15 months demonstrated that MMRV vaccine (containing MMR and varicella) administered concomitantly with DTaP and hepatitis B vaccines produced comparable seroconversion rates and antibody titers to separate administration. 2

  • Immune response preservation: The immune response to MMR, varicella, and other vaccines administered concurrently showed >90% seroconversion for all antigens, confirming no clinically significant interference. 3

  • Safety profile: Concomitant administration of these vaccines is well-tolerated, with safety profiles comparable to separate administration. 2, 4

Critical Principles for Administration

No Spacing Required Between These Vaccines:

  • Inactivated vaccines (DTaP, hepatitis B) can be administered simultaneously or at any time before or after live vaccines (MMR, varicella) without interference. 5

  • The 4-week spacing rule only applies when two live parenteral vaccines are given separately (not simultaneously). 6

  • Since DTaP and hepatitis B are inactivated vaccines, no spacing considerations apply with MMR or varicella. 6

Practical Administration Guidelines:

  • Administer each vaccine at separate anatomic sites using different syringes. 6

  • Preferred injection sites are the anterolateral aspect of the thigh and the deltoid muscle of the upper arm. 1

  • Never mix vaccines in the same syringe unless specifically FDA-approved for mixing. 6

  • Each vaccine should be given as 0.5 mL intramuscularly (DTaP, hepatitis B) or subcutaneously (MMR, varicella). 1, 6

Clinical Benefits of Simultaneous Administration

  • Increases likelihood of complete vaccination and provides timely protection against preventable diseases. 6

  • Approximately one-third of measles cases among unvaccinated preschool children could have been prevented if vaccines had been given simultaneously during prior visits. 6

  • Reduces missed opportunities for vaccination, which is particularly important when uncertainty exists about whether the child will return for future doses. 6

Common Pitfalls to Avoid

  • Do not delay vaccines unnecessarily: There is no medical benefit to spacing these vaccines apart. 6

  • Do not confuse live-to-live vaccine spacing rules with inactivated-to-live administration—DTaP and hepatitis B require no spacing from MMR or varicella. 6

  • Do not use fractional doses: The full 0.5 mL dose must be administered for each vaccine. 1

Contraindications to Consider

Defer vaccination if the child has:

  • Moderate to severe acute illness with or without fever 6
  • Severe allergic reaction (anaphylaxis) to any vaccine component 6
  • Altered immunity or immunodeficiency (specifically affects MMR and varicella vaccines) 6
  • Recent receipt of antibody-containing blood products (affects timing of MMR and varicella vaccines) 6

Documentation Requirements

  • Document all vaccines administered in the child's permanent medical record 6
  • Provide the parent with an updated immunization record 6
  • Schedule follow-up for any remaining doses according to the recommended immunization schedule 6

Related Questions

Can the Measles, Mumps, and Rubella (MMR) vaccine be given together with other vaccines in a healthy pediatric or adult patient?
Can the Varicella (chickenpox) vaccine, Measles, Mumps, and Rubella (MMR) vaccine, and Hepatitis B (Hep B) vaccine be given together?
Can Tdap (Tetanus, diphtheria, and pertussis), polio (Poliomyelitis), MMR (Measles, Mumps, and Rubella), Hep B (Hepatitis B), varicella (Varicella zoster), and MCV4 (Meningococcal conjugate) vaccines be administered together to a 15-year-old patient at the same time?
What vaccinations are recommended for a 4-year-old child?
What is the catch-up vaccination schedule for a 5-year-old child who has missed vaccinations, including Diphtheria, Tetanus, and Pertussis (DTaP) vaccine, Measles, Mumps, and Rubella (MMR) vaccine, Varicella vaccine, and Polio vaccine?
Is it safe to use mikafungin (antifungal medication) and fluconazole (antifungal medication) concurrently in a patient with a compromised immune system or underlying medical conditions?
Can finasteride (a medication for androgenetic alopecia) be compounded into a liquid for effective transdermal application in an adult patient with a history of androgenetic alopecia?
Is it safe to prescribe mikafungin and fluconazole to a patient with myasthenia gravis?
What is the recommended approach for delivering a pregnant patient with a succenturiate lobe placenta?
Is the risk of gynecomastia lower with topical finasteride (for androgenetic alopecia) compared to oral finasteride in adult male patients?
Can you provide images of patients with gynecomastia (enlarged breast tissue in males) after taking oral finasteride (a medication for androgenetic alopecia)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.